Kawahara N - Search Results

1

The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma.

Kawahara N, Kawaguchi R, Maehana T, Yamanaka S, Yamada Y, Kobayashi H, Kimura F. Kawahara N, et al. Biomedicines. 2022 Oct 24;10(11):2683. doi: 10.3390/biomedicines10112683. Biomedicines. 2022. PMID: 36359203 Free PMC article.

2

The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.

Kobayashi H, Iwai K, Niiro E, Morioka S, Yamada Y, Ogawa K, Kawahara N. Kobayashi H, et al. Among authors: kawahara n. Biomed Rep. 2017 Sep;7(3):209-213. doi: 10.3892/br.2017.955. Epub 2017 Jul 27. Biomed Rep. 2017. PMID: 28811894 Free PMC article.

3

Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis.

Kobayashi H, Ogawa K, Kawahara N, Iwai K, Niiro E, Morioka S, Yamada Y. Kobayashi H, et al. Among authors: kawahara n. Free Radic Res. 2017 Oct;51(9-10):755-764. doi: 10.1080/10715762.2017.1383605. Epub 2017 Oct 11. Free Radic Res. 2017. PMID: 28931330 Review.

4

Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer.

Kawahara N, Ogawa K, Nagayasu M, Kimura M, Sasaki Y, Kobayashi H. Kawahara N, et al. Biomed Rep. 2017 Nov;7(5):391-399. doi: 10.3892/br.2017.990. Epub 2017 Sep 27. Biomed Rep. 2017. PMID: 29109859 Free PMC article.

5

Discrimination of malignant transformation from benign endometriosis using a near-infrared approach.

Kawahara N, Yamada Y, Ito F, Hojo W, Iwabuchi T, Kobayashi H. Kawahara N, et al. Exp Ther Med. 2018 Mar;15(3):3000-3005. doi: 10.3892/etm.2018.5779. Epub 2018 Jan 19. Exp Ther Med. 2018. PMID: 29456705 Free PMC article.

6

Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.

Niiro E, Morioka S, Iwai K, Yamada Y, Ogawa K, Kawahara N, Kobayashi H. Niiro E, et al. Among authors: kawahara n. Biomed Rep. 2018 Mar;8(3):215-223. doi: 10.3892/br.2018.1045. Epub 2018 Jan 17. Biomed Rep. 2018. PMID: 29564122 Free PMC article.

7

Conceptual frameworks of synthetic lethality in clear cell carcinoma of the ovary.

Kobayashi H, Kawahara N, Ogawa K, Yamada Y, Iwai K, Niiro E, Morioka S. Kobayashi H, et al. Among authors: kawahara n. Biomed Rep. 2018 Aug;9(2):112-118. doi: 10.3892/br.2018.1114. Epub 2018 Jun 20. Biomed Rep. 2018. PMID: 30013776 Free PMC article. Review.

8

Comparison of redox parameters in ovarian endometrioma and its malignant transformation.

Fujimoto Y, Imanaka S, Yamada Y, Ogawa K, Ito F, Kawahara N, Yoshimoto C, Kobayashi H. Fujimoto Y, et al. Among authors: kawahara n. Oncol Lett. 2018 Oct;16(4):5257-5264. doi: 10.3892/ol.2018.9242. Epub 2018 Jul 31. Oncol Lett. 2018. PMID: 30214615 Free PMC article.

9

Clinical significance of M2 macrophages expressing heme oxygenase-1 in malignant transformation of ovarian endometrioma.

Yamada Y, Uchiyama T, Ito F, Kawahara N, Ogawa K, Obayashi C, Kobayashi H. Yamada Y, et al. Among authors: kawahara n. Pathol Res Pract. 2019 Apr;215(4):639-643. doi: 10.1016/j.prp.2018.12.017. Epub 2018 Dec 12. Pathol Res Pract. 2019. PMID: 30567635

10

Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.

Kobayashi H, Yamada Y, Kawahara N, Ogawa K, Yoshimoto C. Kobayashi H, et al. Among authors: kawahara n. Oncol Rep. 2019 Mar;41(3):1729-1738. doi: 10.3892/or.2018.6946. Epub 2018 Dec 21. Oncol Rep. 2019. PMID: 30592289 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

675 results

Search Page

Filters